doxepin hydrochloride NDC 0093-9609

NDC codes

FDA NDC Directory

Product NDC (as listed)0093-9609Labeler and product segments. Claims need a package NDC.

Product NDC at billing width00093-9609Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
0093-9609-95	00093960995	1 TUBE in 1 CARTON (0093-9609-95) / 45 g in 1 TUBEMarketed from Feb 17, 2023

How the 11-digit form is made: The labeler segment has 4 digits, so one leading zero is added to it (4-4-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): doxepin hydrochloride
Generic name (nonproprietary): doxepin hydrochloride
Active ingredients: Doxepin hydrochloride — 50 mg/g
Dosage form: Cream
Route: Topical
Labeler: Teva Pharmaceuticals USA, Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 215408
Marketing start: Feb 17, 2023
Listing expires: Dec 31, 2026
Identifiers: Product ID 0093-9609_7d22a419-3d33-492c-b054-fb29a82ce643SPL ID 7d22a419-3d33-492c-b054-fb29a82ce643SPL set ID 4a4eab1c-8e19-48f5-9216-09ab83eaa5f8RxCUI 1000091UNII 3U9A0FE9N5UPC 0300939609955
Pharmacologic class: Tricyclic Antidepressant

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N400093960995 followed by a unit qualifier and the quantity

Package 00093-9609-95. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 1, 2021.

Indications (excerpt from the label)

INDICATIONS AND USAGE Doxepin hydrochloride cream, 5% is indicated for the short-term (up to 8 days) management of moderate pruritus in adult patients with atopic dermatitis or lichen simplex chronicus (see DOSAGE AND ADMINISTRATION ).

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)